Our Company
Established in Europe in 2009, we are a multinational group that operates internationally and enjoys a strong presence in the major pharmaceutical markets. mAbxience is also fully committed [...]
About Us
Dr. Sigman and his biochemist wife, Silvia Gold, founded mAbxience in 2009 as the biotechnology arm of the CHEMO Group, which the couple set up in 1977. Hugo [...]
mAbBLOG
Extrapolation of indications on biosimilars+
The extrapolation of indications for a biosimilar consists in the regulatory approval of the biosimilar drug for the treatment of diseases that have not been specifically studied during [...]